Reuters logo
3 个月前
BRIEF-Pfizer says for co’s U.S. biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4 pct in the U.S.
2017年6月2日 / 晚上6点43分 / 3 个月前

BRIEF-Pfizer says for co’s U.S. biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4 pct in the U.S.

June 2 (Reuters) - Pfizer Inc:

* "For Pfizer’s US Biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4% in the US"‍​ Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below